FDA NDC Directory · JSON-LD · Markdown

Fluvoxamine maleate extended-release

NDC 70710-1848 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerZydus Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA220447
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsFLUVOXAMINE MALEATE (150 mg/1)
Marketing started20260804
Package count1

External sources

Source: openFDA. Public-domain (CC0).